C
Chabiotech Co Ltd
KOSDAQ:085660
Chabiotech Co Ltd
KOSDAQ:085660
Price:
14 860
KRW
-2.49%
Market Cap:
836.8B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Chabiotech Co Ltd
14860
-380 (-2.49%)
| 52 Week Range |
13 370
19 870
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Chabiotech Co Ltd
Balance Sheet
Balance Sheet Decomposition
Chabiotech Co Ltd
Chabiotech Co Ltd
| Current Assets | 661.4B |
| Cash & Short-Term Investments | 268.6B |
| Receivables | 301.4B |
| Other Current Assets | 91.4B |
| Non-Current Assets | 1.4T |
| Long-Term Investments | 118.9B |
| PP&E | 945.5B |
| Intangibles | 256.3B |
| Other Non-Current Assets | 87.9B |
| Current Liabilities | 961.8B |
| Accounts Payable | 89.5B |
| Accrued Liabilities | 39.3B |
| Short-Term Debt | 66.2B |
| Other Current Liabilities | 766.7B |
| Non-Current Liabilities | 775.2B |
| Long-Term Debt | 228.3B |
| Other Non-Current Liabilities | 546.9B |
Balance Sheet
Chabiotech Co Ltd
Chabiotech Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
129 396
|
164 279
|
133 878
|
114 553
|
89 509
|
117 358
|
121 164
|
122 521
|
66 603
|
60 694
|
|
| Cash |
129 396
|
164 279
|
133 878
|
114 553
|
89 509
|
117 358
|
121 164
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
122 521
|
66 603
|
60 694
|
|
| Short-Term Investments |
80 232
|
98 371
|
186 565
|
176 567
|
165 138
|
175 503
|
222 669
|
206 383
|
171 721
|
141 636
|
|
| Total Receivables |
123 963
|
83 651
|
112 695
|
141 338
|
177 729
|
180 104
|
176 850
|
174 464
|
210 978
|
255 337
|
|
| Accounts Receivables |
51 770
|
57 405
|
57 485
|
57 884
|
66 530
|
77 905
|
66 659
|
83 871
|
93 177
|
99 494
|
|
| Other Receivables |
72 193
|
26 246
|
55 210
|
83 454
|
111 199
|
102 199
|
110 191
|
90 593
|
117 802
|
155 843
|
|
| Inventory |
7 615
|
9 090
|
11 456
|
14 659
|
13 307
|
17 799
|
25 129
|
25 105
|
32 804
|
34 117
|
|
| Other Current Assets |
16 757
|
14 709
|
18 418
|
24 589
|
17 876
|
18 386
|
22 164
|
48 444
|
38 161
|
46 438
|
|
| Total Current Assets |
357 963
|
370 100
|
463 012
|
471 704
|
463 558
|
509 150
|
567 976
|
576 916
|
520 267
|
538 222
|
|
| PP&E Net |
130 487
|
143 513
|
159 161
|
169 514
|
243 918
|
371 721
|
478 494
|
672 081
|
805 021
|
853 481
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
805 021
|
853 481
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24 007
|
30 154
|
|
| Intangible Assets |
50 612
|
42 839
|
46 061
|
15 853
|
19 770
|
20 081
|
18 524
|
17 986
|
24 773
|
24 782
|
|
| Goodwill |
7 394
|
7 508
|
7 394
|
7 394
|
32 644
|
33 392
|
34 263
|
35 004
|
58 742
|
62 335
|
|
| Note Receivable |
0
|
5 860
|
5 867
|
4 500
|
4 891
|
1 379
|
5 777
|
9 264
|
423
|
5 285
|
|
| Long-Term Investments |
36 944
|
33 055
|
42 326
|
69 038
|
81 038
|
173 940
|
119 100
|
123 385
|
92 964
|
101 668
|
|
| Other Long-Term Assets |
37 485
|
41 956
|
45 109
|
55 605
|
101 713
|
53 260
|
89 577
|
100 489
|
104 819
|
139 799
|
|
| Other Assets |
7 394
|
7 508
|
7 394
|
7 394
|
32 644
|
33 392
|
34 263
|
35 004
|
58 742
|
62 335
|
|
| Total Assets |
620 885
N/A
|
644 831
+4%
|
768 929
+19%
|
793 608
+3%
|
947 532
+19%
|
1 162 923
+23%
|
1 313 710
+13%
|
1 535 125
+17%
|
1 607 008
+5%
|
1 725 570
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
14 670
|
19 663
|
27 729
|
17 474
|
22 631
|
29 065
|
31 934
|
44 472
|
71 744
|
80 331
|
|
| Accrued Liabilities |
11 680
|
12 790
|
14 067
|
14 724
|
20 126
|
21 394
|
24 225
|
29 774
|
32 729
|
35 512
|
|
| Short-Term Debt |
3 605
|
3 006
|
3 000
|
5 373
|
5 533
|
10 317
|
16 271
|
16 951
|
15 166
|
22 114
|
|
| Current Portion of Long-Term Debt |
5 248
|
32 228
|
174 374
|
36 717
|
37 712
|
27 348
|
45 859
|
85 685
|
50 893
|
285 776
|
|
| Other Current Liabilities |
64 540
|
47 832
|
46 959
|
154 960
|
141 936
|
127 784
|
167 389
|
244 657
|
307 217
|
222 438
|
|
| Total Current Liabilities |
99 743
|
115 519
|
266 129
|
229 248
|
227 938
|
215 908
|
285 678
|
421 538
|
477 748
|
646 171
|
|
| Long-Term Debt |
14 638
|
5 792
|
32 439
|
65 554
|
87 753
|
186 036
|
244 136
|
231 201
|
334 801
|
141 745
|
|
| Deferred Income Tax |
334
|
3 605
|
2 656
|
2 220
|
3 133
|
2 005
|
15 148
|
9 939
|
3 231
|
1 898
|
|
| Minority Interest |
140 229
|
156 460
|
92 540
|
177 715
|
223 256
|
289 115
|
281 781
|
337 056
|
360 204
|
374 987
|
|
| Other Liabilities |
68 715
|
73 352
|
88 844
|
88 131
|
78 460
|
92 676
|
131 872
|
79 335
|
139 291
|
279 423
|
|
| Total Liabilities |
323 659
N/A
|
354 728
+10%
|
482 608
+36%
|
562 868
+17%
|
620 541
+10%
|
785 740
+27%
|
958 616
+22%
|
1 079 069
+13%
|
1 315 276
+22%
|
1 444 223
+10%
|
|
| Equity | |||||||||||
| Common Stock |
25 101
|
25 247
|
25 291
|
25 627
|
26 239
|
26 240
|
26 275
|
28 130
|
28 134
|
28 157
|
|
| Retained Earnings |
66 401
|
53 744
|
109 256
|
9 372
|
70 585
|
115 659
|
97 330
|
83 666
|
38 158
|
28 282
|
|
| Additional Paid In Capital |
207 929
|
188 924
|
191 459
|
204 017
|
248 591
|
272 687
|
274 253
|
360 309
|
361 649
|
362 936
|
|
| Unrealized Security Profit/Loss |
3 082
|
1 230
|
1 342
|
1 931
|
11 103
|
10 753
|
9 811
|
13 598
|
11 929
|
13 233
|
|
| Treasury Stock |
5 897
|
7 820
|
7 820
|
7 820
|
2 402
|
2 402
|
2 402
|
2 402
|
2 402
|
3 584
|
|
| Other Equity |
6 774
|
28 778
|
33 206
|
2 385
|
4 918
|
24 248
|
30 551
|
50
|
121 878
|
121 212
|
|
| Total Equity |
297 225
N/A
|
290 103
-2%
|
286 321
-1%
|
230 740
-19%
|
326 991
+42%
|
377 183
+15%
|
355 094
-6%
|
456 056
+28%
|
291 732
-36%
|
281 347
-4%
|
|
| Total Liabilities & Equity |
620 885
N/A
|
644 831
+4%
|
768 929
+19%
|
793 608
+3%
|
947 532
+19%
|
1 162 923
+23%
|
1 313 710
+13%
|
1 535 125
+17%
|
1 607 008
+5%
|
1 725 570
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
49
|
49
|
49
|
50
|
52
|
52
|
53
|
56
|
56
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
